Quest Diagnostics 1999 Annual Report Download - page 14

Investor Information
Common Stock
Shares in Quest Diagnostics
Incorporated (ticker symbol:
“DGX”) are listed on the New York
Stock Exchange. Options on Quest
Diagnostics shares are traded on
the Chicago Board Options
Exchange.
Corporate Headquarters
One Malcolm Avenue
Teterboro, New Jersey 07608
[phone]
Annual Meeting
The next annual meeting of
shareholders will be held on
May 9, 2000 in New York City.
A proxy statement and annual
report were mailed to shareholders
of record as of March 10, 2000.
Additional Information
Address all inquiries to:
Investor Relations Department
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, New Jersey 07608
[phone]
Annual Report on Form 10-K
A copy of the Quest Diagnostics
1999 Annual Report on Form
10-K, filed with the Securities and
Exchange Commission, is contained
in this Annual Report, starting
after page 10. Additional copies
are available without charge by
contacting the Investor Relations
Department.
Internet Access
Corporate news releases, our
annual report, Forms 10-K and
10-Q and other information about
the company are available
through Quest Diagnostics’ web
site on the Internet:
http://www.questdiagnostics.com
Transfer Agent and Registrar
Harris Trust and Savings Bank
311 West Monroe Street
Chicago, Illinois 60606
[phone]
Report change of address to
Harris Bank at the above address.
Quest Diagnostics has not
declared any dividends on
common stock.
“Safe Harbor” Statement under
the Private Securities Litigation
Reform Act of 1995
The statements in this Annual
Report whichare not historical facts
or information are forward-looking
statements. These forward-looking
statements involve risks and
uncertainties that could cause the
outcome to be materially different.
Certain of these risks and
uncertainties are listed in the
1999 Annual Report on Form
10-K. These risksand uncertainties
include heightened competition,
impact of changes in payer mix,
adverse actions by governmental
and other third-party payers, the
impact upon Quest Diagnostics’
collection rates or general or
administrative expenses resulting
from compliance with Medicare
administrative policies, inability to
efficiently integrate acquired
clinical laboratory businesses,
particularly SBCL’s, adverse results
from pending governmental
investigations, reduction in tests
ordered by existing customers,
material increases in premiums for
insurance coverage, denial of
licensure, computer or other
system failures, development of
technologies that substantially
alter the practice of medicine, and
changes in interest rates.
Compliance
Quest Diagnostics is committed to
the highest ethical standards and
complying with all applicable laws
and regulations that govern its
Emeritus whose long career
includes service as Director of
Laboratories and Chief Pathologist
at St. Luke’s-Roosevelt Hospital in
New York City as well as a tenured
professorship of pathology at
the Columbia University College
of Physicians and Surgeons.
1999 Winner:
Horsham, Pennsylvania
1999 Challengers:
Denver, Colorado
San Diego, California
SmithKline Beecham Clinical
Laboratories (SBCL) had presented
the Eagle Award to honor service
excellence and outstanding
performance. The final Eagle
Award was presented for 1999 to
the Southeast Region based in
Tucker, Georgia.
Trademarks
Quest Diagnostics, Quest, the
symbol and all other names and
logos are trademarks of Quest
Diagnostics Incorporated.
SmithKline Beecham Clinical
Laboratories, SmithKline
Beecham, SBCL, SB and the
associated logo are trademarks of
SmithKline Beecham plc and are
used under license.
ThinPrep® Pap Test™is a
registered trademark of
Cytyc Corporation.
TheDailyApple.com™is a
trademark of Caresoft, Inc.
Neither this report nor any
statement contained herein is
furnished in connection with any
offering of securities or for the
purpose of promoting or
influencing the sale of securities.
© 2000 Quest Diagnostics Incorporated.
All rights reserved.
business operations, including
those that apply to reimbursement
for testing under the federal
Medicare and Medicaid programs.
Quest Diagnostics requires that all
employees abide by these laws,
rules and regulations and provides
annual compliance training for all
employees. Quest Diagnostics is
committed to protecting the
health and safety of its employees
as well as the environmental
resources of the communities in
which it operates.
Diversity
Quest Diagnostics is an Equal
Employment Opportunity and
Affirmative Action employer
committed to creating and
maintaining a diverse work force.
The company recruits, hires, trains,
develops and promotes individuals
for all positions regardless of race,
gender,age,religion, national origin,
sexual orientation, disability, or
status as a disabled veteran or
Vietnam era veteran.
reach!
Our national volunteer program,
called reach! (remember every
act can help), is employee-driven
and encourages everyone at
Quest Diagnostics to contribute
to the communities in which they
live and work, thereby helping to
improve the lives of those who
use our services every day.
Quest Diagnostics, through
the reach! program, is a National
Supporter of the Juvenile Diabetes
Foundation and supports numerous
other charitable organizations
throughout the United States.
The Raymond Gambino
Quality Award
The purpose of the Raymond
Gambino Quality Award is to
encourage and recognize
quality excellence within
Quest Diagnostics. The award is
named for Quest Diagnostics’
distinguished Chief Medical Officer
12